Concepedia

Iris L. van Staveren

IL

23

Publications

2.3K

Citations

22

H-Index

1992

Active since

Affiliations

Rotterdam University of Applied Sciences(Current)

Erasmus University Rotterdam

Erasmus MC

Erasmus MC Cancer Institute

Meertens Institute

Iris L. van Staveren is an author at Rotterdam University of Applied Sciences specializing in medicine, breast cancer, and oncology.

Top concepts

Publications per year

1992–2010

23

Publications

23

Molecular Classification of Tamoxifen-Resistant Breast Carcinomas by Gene Expression Profiling

Maurice P.H.M. Jansen, John A. Foekens, Iris L. van Staveren et al. · Journal of Clinical Oncology · 2005 · 331 citations · Full text

c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer.

E. Berns, J.G.M. Klijn, W L van Putten et al. · PubMed · 1992 · 206 citations

, , +13

Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer.

E. Berns, John A. Foekens, R. van Vossen et al. · PubMed · 2000 · 197 citations

, , +19

Oncogene amplification and prognosis in breast cancer: Relationship with systemic treatment

Els M.J.J. Berns, John A. Foekens, Iris L. van Staveren et al. · Gene · 1995 · 175 citations

, , +7

Association of an Extracellular Matrix Gene Cluster with Breast Cancer Prognosis and Endocrine Therapy Response

Jozien Helleman, Maurice P.H.M. Jansen, Kirsten Ruigrok-Ritstier et al. · Clinical Cancer Research · 2008 · 171 citations · Full text

Rows per page

1–5 of 23